Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TRIB2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | SYNC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
mRNA | ZNF311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | EHHADH | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GAS6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | ETV1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | KRT82 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | HOMER1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CXorf49B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | CEP120 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |